Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-02
DOI
10.1186/s13195-019-0555-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Biomarker Changes in Presymptomatic Genetic Frontotemporal Dementia
- (2019) Alberto Benussi et al. NEUROBIOLOGY OF AGING
- Added value of 18 F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study
- (2018) Mathieu Ceccaldi et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Neurotransmitter deficits from frontotemporal lobar degeneration
- (2018) Alexander G Murley et al. BRAIN
- Discrimination of atypical parkinsonisms with transcranial magnetic stimulation
- (2018) Alberto Benussi et al. Brain Stimulation
- Diagnosis of Mild Cognitive Impairment Due to Alzheimer’s Disease with Transcranial Magnetic Stimulation
- (2018) Alessandro Padovani et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
- (2018) Ross W. Paterson et al. Alzheimers Research & Therapy
- The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
- (2018) Alberto Benussi et al. Alzheimers Research & Therapy
- Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
- (2017) Giovanni B Frisoni et al. LANCET NEUROLOGY
- Practice guideline update summary: Mild cognitive impairment
- (2017) Ronald C. Petersen et al. NEUROLOGY
- Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia
- (2017) Alberto Benussi et al. NEUROLOGY
- Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia
- (2016) Alberto Benussi et al. ANNALS OF NEUROLOGY
- Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment
- (2016) Marina Boccardi et al. JAMA Neurology
- Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations
- (2016) Ahmad A. Khundakar et al. Acta Neuropathologica Communications
- Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee
- (2015) P.M. Rossini et al. CLINICAL NEUROPHYSIOLOGY
- TMS and drugs revisited 2014
- (2015) Ulf Ziemann et al. CLINICAL NEUROPHYSIOLOGY
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
- (2014) Barbara Borroni et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- (2010) L. C. de Souza et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
- (2009) Joseph L. Price et al. NEUROBIOLOGY OF AGING
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More